Swiss Drugmaker Novartis
- All
- News
- Videos
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
Heart Drug Could Be "Most Exciting Ever", Says Novartis
Swiss drugmaker Novartis has unveiled strikingly good clinical trial results for a new heart failure drug that might be the biggest pharmaceutical advance in a quarter of century.
-
Novartis and Google to Develop 'Smart' Contact Lens
Swiss drugmaker Novartis has struck an agreement with Google to develop "smart" contact lenses that would help diabetics track their blood glucose levels or restore the eye's ability to focus.
-
US sues Novartis over kickbacks, second case this week
The US government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multimillion-dollar kickbacks to doctors in exchange for prescribing its drugs.
-
Novartis on patent setback: Will continue to invest in India, but cautiously
Novartis India Limited, a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, its vice chairman said on Monday, after the country's top court rejected its plea for patent protection of its drug Glivec.
-
Supreme Court rejects Novartis AG's plea for cancer drug patent: Read full verdict
The Supreme Court has dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales. Here is the copy of the full verdict:
-
Novartis AG's plea for Glivec patent dismissed by Supreme Court
The Supreme Court dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive sales and a victory for local makers of cheap generics.
-
Swiss Drugmaker Novartis To Help Make Pfizer-Biontech Coronavirus Vaccine
Swiss drugmaker Novartis has signed an initial agreement to provide manufacturing capacity for Pfizer and Biontech's COVID-19 vaccine, a move aimed at helping boost production as supplies fall shy of demand.
-
Heart Drug Could Be "Most Exciting Ever", Says Novartis
Swiss drugmaker Novartis has unveiled strikingly good clinical trial results for a new heart failure drug that might be the biggest pharmaceutical advance in a quarter of century.
-
Novartis and Google to Develop 'Smart' Contact Lens
Swiss drugmaker Novartis has struck an agreement with Google to develop "smart" contact lenses that would help diabetics track their blood glucose levels or restore the eye's ability to focus.
-
US sues Novartis over kickbacks, second case this week
The US government on Friday announced its second civil fraud lawsuit against Novartis AG in four days, accusing a unit of the Swiss drugmaker of paying multimillion-dollar kickbacks to doctors in exchange for prescribing its drugs.
-
Novartis on patent setback: Will continue to invest in India, but cautiously
Novartis India Limited, a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, its vice chairman said on Monday, after the country's top court rejected its plea for patent protection of its drug Glivec.
-
Supreme Court rejects Novartis AG's plea for cancer drug patent: Read full verdict
The Supreme Court has dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales. Here is the copy of the full verdict:
-
Novartis AG's plea for Glivec patent dismissed by Supreme Court
The Supreme Court dismissed Swiss drugmaker Novartis AG's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive sales and a victory for local makers of cheap generics.
